Exchange: NASDAQ·Updated 12:39 PM EST
MBOT logo

MBOT Microbot Medical Inc

$1.04
$0.06
(5.46%)
Today
Mkt Cap$73.88M
Vol490,573.00

About MBOT

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
55

Bullish Sentiment

How do you feel about MBOT?

Prash83
$MBOT one OBL normally runs 8-10 procedures per day -yearly 1500-2000 Say if they target 300-500 per year with liberty - if we consider hypothetical cost per liberty 2000$ Not difficult to get 1million per OBL! On top previous users has already reordered We expect 4 more account until December end- with second manufacturer in place we should see volume rise per quarter.
1
12
gladee88er
$MBOT If anyone wants to get an idea how long it takes to work a new Medtech device through the system, go to LinkedIn and check out Jeremy Kim, MD's profile. Kim is a Vascular & Interventional Specialist, and a nationally recognized expert in men's health treatments. He JUST announced that they have completed the first-ever robotic assisted PAE procedures in the Carolinas using the Liberty system (Charlotte, NC). MBOT first announced the NC hospital system in a June 2nd announcement. We're talking over 4 months to get the first successful procedures completed. It's a slow process in the beginning, but this will gain traction in 2027.
15
D541
$MBOT for me for this time is a NO, if they start delivering and if they do some open market purchase then they can ask again and I'm happy to vote yes. My only holding where the insiders have not purchased a single share since I am here, well before approval
8
SouthHaus
$MBOT The most encouraging quote from Dr. Steinberger, in my opinion? “Based on our experience to date, LIBERTY is well positioned to become a standard for the use of robotics in endovascular intervention procedures.”
11
Nocluewhatimdoin_
$MBOT voted no , tired of every companies board members trying to reward themselves and dilute the shareholders without delivering anything substantial to retail holders.
8
D541
$MBOT all the best to MBOT and the investors here, holding strong ! Patience will be rewarded
10
leLu83
$MBOT as all regions are sales active it should bring higher amounts of customers. California and the West lead in robotics purchases in general per region. Northeast and South, Texas lead the packs. Its good to get places already using a da vinci or robotics aligned hospitals where the disposable system will be seen as a major value add.
9
Wayne_Schlagel
$MBOT I think I bought enough shares to sit and wait… my favorite small cap company hands down
9
D541
$MBOT price barely above 1 and they ask for 1M shares for future rewards, unbelievable. Zero insiders purchase and they want us to pay for them. The product ok, the sales are going better but the shareholders value has not been returned yet. Deliver first then ask for compensation
7
Prash83
$MBOT two more good news on earning and increased accounts with reordering… This may fly!
7
StocksGoddess
$MBOT Microbot Medical Inc. (Nasdaq: MBOT)today announced that ELMNT IR, a multisite outpatient interventional radiology practice in California, has signed an order to purchase up to a 12-month supply of LIBERTY devices. ELMNT IR became the first Office-Based Laboratory (OBL) customer in the world to utilize the LIBERTY Endovascular Robotic System, and the Company's first customer on the West Coast. An OBL is an outpatient care setting that enables physicians to perform minimally invasive, image-guided procedures outside of the traditional hospital environment.
7
Rayvio_News_Filter
$MBOT 📝 Microbot Medical Inc. announced that ELMNT IR signed an order to purchase up to a 12-month supply of LIBERTY endovascular robotic devices, marking its first office-based lab customer and first West Coast account.
7
Lordlittle
$MBOT I fully believe now when ce mark for Europe gets approved England nhs will buy it
5
leLu83
$MBOT large bid at 108 to let the dawgs hunt. Double tap EMA and an earnings beat and you got yourself back to a 200M market cap fast.
5
Merlintrader
$MBOT — First office-based lab customer for LIBERTY; supply up to 12 months. Information only — not investment advice. More details in our hub.
5
Reddyrob
$MBOT the management has to understand that news won't drive price anymore. Just bring sales or start buying a few shares in your own company.
5
leLu83
$MBOT why get your phd if you have to wear lead aprons and take unnecessary radiation? 2026 and robotics still is under saturated in the market. People want robots and AI when they get medical procedures. Look at how the hospitals market isrg mazor corindus products to build a brand of we have the best and latest tech. Physicians should be pounding the table to bring this into their labs.
4
Djmorri
$MBOT This Company been surviving off of big promises and dilution for years ! Revenue is always missing
2
rubraquercus
$MBOT My new biotech mantra is loading up on approved drugs/devices when they get crushed...it was over $2 last November on approval, the future is bright as sales are ramping...
2
GladysFoster
$MBOT probably in for another small drop today to around the 0.88 cents area and then I am very much hoping for the bounce/double bounce back on up from early next week. Just my thoughts
2

Advertisement|Remove ads.